Article Versions Notes

Eljilany I, Noor A, Paravathaneni M, Yassine I, Lee SJ, Othus M, Moon J, Kirkwood JM, Sondak VK, Ribas A, et al. Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review. Cancers. 2023; 15(9):2561. https://doi.org/10.3390/cancers15092561

Eljilany, Islam, Arish Noor, Mahati Paravathaneni, Ibrahim Yassine, Sandra J. Lee, Megan Othus, James Moon, John M. Kirkwood, Vernon K. Sondak, Antoni Ribas, and et al. 2023. "Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review" Cancers 15, no. 9: 2561. https://doi.org/10.3390/cancers15092561

Eljilany, I., Noor, A., Paravathaneni, M., Yassine, I., Lee, S. J., Othus, M., Moon, J., Kirkwood, J. M., Sondak, V. K., Ribas, A., Grossmann, K. F., & Tarhini, A. A. (2023). Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review. Cancers, 15(9), 2561. https://doi.org/10.3390/cancers15092561